; if homozygous for wild type the tumor has been initiated before COX-2 is expressed. COX-2, they developed an average of 652 polyps at 10 However, Boolbol et al. (1996) obtained a directly conweeks, while heterozygotes had 224 polyps and homoflicting result-that the uninvolved epithelium in Min zygously deficient mice had only 93 polyps. This experimice did have increased COX-2, which will need to be ment provided definitive genetic evidence that induction assessed further in mice and humans. We conclude that of COX-2 is an early, rate-limiting step for adenoma the current evidence supports this sequence of events: formation. As supporting evidence, a drug that inhibits loss of both APC alleles, early polyp formation, expres-COX-2 but not COX-1 also markedly reduced the numsion of COX-2, polyp growth, and additional mutations ber of polyps. Thus, a mouse model again has proven to reach an invasive tumor (Figure 1 ). Thus, COX-2 exvaluable for measuring a quantitative genetic effect and pression would be past the boundary of tumor establishPtgs2 (the COX-2 gene in mouse terminology) can be ment (Dove et al., 1995) and would provide a mechanism added to the list of genes involved in colon neoplasia for self-promotion by the early adenoma. (Dove et al., 1995) .
The events between loss of the second APC allele and Overexpression of COX-2 Is an Early, Central Event COX-2 expression are unknown. One likely possibility is in Carcinogenesis that transcription of COX-2, which does not occur con-A connection between prostaglandins and colon carcistitutively, is switched on. We found that a colon cancer nogenesis has been recognized for some time; epidecell line that expresses COX-2 also transcribes a COX-2 miological studies have shown that chronic intake of reporter gene, which is consistent with this hypothesis nonsteroidal anti-inflammatory drugs (NSAIDs), which (Kutchera et al., 1996) . There is substantial information function as COX inhibitors, reduce colon cancer and about the transcriptional regulation of COX-2 (Herschpolyps by as much as 40%. NSAIDs prolong the lag man, 1994), but it is not clear how loss of APC function phase prior to the appearance of colon cancer induced would activate these pathways. Another mechanism is by chemical carcinogens in animals and decrease the suggested by recent studies of APC function: APC binds number of polyps in Min mice (Jacoby et al., 1996) .
to ␤-catenin and it, in turn, binds and regulates the Finally, the size and number of polyps in FAP patients transcription factor LEF-1 (Kinzler and Vogelstein, 1996) . decrease markedly in response to the NSAID sulindac LEF-1 is not known to regulate COX-2 expression, but (Giardiello et al., 1993). There was substantial circumsuch a mechanism could link APC loss with increased COX-2 transcription. stantial evidence that COX-2 was the culprit; COX-1 Recent evidence (including Oshima et al., 1996) places COX-2 after the loss of the second allele of APC and the morphological appearance of a very early polyp (<2 mm). Mice that are genetically altered to be COX-2 deficient, or that receive a selective inhibitor of COX-2, are strongly protected against the development of colon polyps even with a germline mutation in APC. The steps between functional loss of both APC alleles and increased expression of COX-2 are unknown but likely involve increased transcription of this normally silent gene. Once expressed, the majority of COX-2 is strategically located in the nuclear membrane (DeWitt and Smith, 1995) . The mechanism(s) by which increased prostaglandin synthesis promote tumorigenesis also is unknown but there are several promising clues. One intriguing finding is that expression of COX-2 impairs the apoptotic response (Tsujii and DuBois, 1995) .
In a recent minireview, DeWitt and Smith (1995) asked but remained far higher than mice that were APC ϩ/ϩ . Thus, there clearly is a way around COX-2: is it COX-1, whether increased COX-2 has a causal role in colon or another oxidase? It would be interesting to test carcinogenesis. This question now is resolved: COX-2 whether a COX-1 inhibitor reduces the neoplasia in is on the causal pathway. In its absence-whether by COX-2 deficient/APC ϩ/-mice relative to that of control pharmacological inhibition or genetic alteration-adeanimals. noma formation is substantially impaired. A related How Do COX-2 Reaction Products Contribute question posed then was, if COX-2 has a causal role to Tumorigenesis? why isn't its expression consistently observed in human
Prostaglandins are a diverse family of lipid mediators polyps at an early stage? The answers to the seeming derived from arachidonic acid. The committed step in paradox are arriving. In part, the previous results could their synthesis is prostaglandin H synthase (COX), which have reflected simply a lack of sufficient sensitivity in catalyzes two reactions (Figure 2) . The cyclooxygenase the methods applied. Also, recent reports have lessened reaction incorporates two moles of oxygen per mole of the paradox: both Oshima et al. (1996) and Williams et arachidonic acid to yield PGG2. This intermediate is al . (1996) found that the adenomas from APC ϩ/ϩ mice reduced by the peroxidase activity of COX to PGH2 have increased expression of COX-2. Finally, many of which, in turn, can be converted by other enzymes into the adenomas negative for COX-2 were sporadic, and one of many terminal prostaglandins. Alternatively, sporadic adenomas may follow a different pathway. Be-PGH2 can break down to a direct mutagen, malondialdecause mutation or deletion of APC is frequently obhyde, which forms adducts with deoxynucleosides. The served in sporadic polyps, it seems unlikely that the peroxidase reaction could be important in carcinogenesporadic pathway is completely different, but the quessis since it requires a cofactor as the reductant; many tion still remains as to whether the sporadic pathway depends as heavily on COX-2. Also, another inherited syndrome, Hereditary Nonpolyposis Colorectal Cancer (which does have polyps in spite of the name), is initiated through mutation of DNA mismatch repair genes. Does this pathway involve COX-2? The colon cancer cell line HCT116 has constitutive expression of COX-2 (Kutchera et al., 1996) , but has a mutation in a mismatch repair gene and expresses normal APC alleles. Is this a coincidence resulting from a later mutation or does it indicate that COX-2 is an early event in both pathways?
The demonstration of an important role for COX-2 in colon neoplasia raises the question of whether it is absolutely essential. The answer seems to be no, even though it appears to be the standard early step on the APC pathway. The best evidence against an absolute role comes again from the results from Oshima et al. immunohistochemistry even though it was evident by western blotting. To address this, they constructed a mouse with ␤-galactosidase under the control of the COX-2 promoter. Their surprising result was that expression was observed in interstitial, rather than epithelial, cells. If this reflects expression of the endogenous COX-2 gene, the implications would be profound-the role of COX-2 products presumably would be through paracrine signaling and not by a cell-autonomous mechanism. This would raise many more questions, including whether the interstitial cells are responding to a signal from epithelial cells to induce COX-2. However, this result needs more investigation since it is at odds with other findings in the Min mouse (Williams et al., 1996) and human tissues (Sano et al., 1995; Kutchera et al., 1996) , in which neoplastic epithelial cells had markedly increased COX-2 expression. Future Prospects Oshima et al. (1996) have proven that COX-2 expression broadly effective in chemoprevention of colon cancer. Much remains to be learned: in the clinic, will specific inhibitors of COX-2 be more effective than those that compounds (for example, xenobiotics such as aflatoxin) inhibit both isoforms? Will inhibition of COX-2 be as can be oxidized by COX to mutagens (Marnett, 1994, effective in sporadic polyps and HNPCC as in FAP paand references therein). This might be a particularly imtients? What accounts for the residual cases of neoplaportant mechanism in the colon since the epithelial cells sia-is it a rare event that occurs only in some early are continuously exposed to xenobiotics.
polyps, or will all of them eventually escape the inhibitory It seems most likely that the products of COX-2 cause effect? How should chemoprevention with COX inhibitumor promotion, but prostaglandins also are known to tors be integrated into current surveillance and intervenalter cell growth. This probably occurs through paracrine tion protocols? In the laboratory, there also are imporor autocrine signaling through prostaglandin receptors, tant questions: how does COX-2 expression become which are members of the G protein-coupled family of dysregulated after loss of APC function? Is it transcripreceptors ( Figure 3) . The signals depend on the specific tional, and, if so, through which factors? Is COX-2 exagonist and receptor, but include changes in cyclic pression alone sufficient to cause colon neoplasia? AMP, turnover of phosphatidylinositol, and activation of What are the important products and what is the signalboth PKC and MAP kinase. Another possibility is that ing pathway? Which cellular responses lead to tumors COX-2 regulates apoptosis in colonic epithelial cells. In (e.g., loss of apoptosis, others)? The distance ahead normal colon, the epithelial cells arise from stem cells, shouldn't obscure how successful the journey has been differentiate, and then undergo apoptosis, which several already: an early, central biochemical step in colon carcigroups have shown to be decreased in tumorigenesis nogenesis has been identified by pharmacological and (reviewed by Kinzler and Vogelstein, 1996) . An important genetic approaches. Also, there are safe inhibitors of the insight into this process came from Tsujii and DuBois enzyme, suggesting that application to clinical practice (1995), who showed that overexpression of COX-2 in should follow promptly. a rat intestinal cell line prevented apoptosis, and that apoptosis was restored by treatment with a COX inhibi-
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tor. This strongly suggested that a product of COX-2
